SI
CRL icon

Sapience Investments’s Charles River Laboratories CRL Stock Holding History

Sapience Investments’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,353
Closed -$463K – 87
2024
Q3 		$463K Hold
2,353
– – 0.23% 85
2024
Q2 		$486K Hold
2,353
– – 0.25% 81
2024
Q1 		$638K Hold
2,353
– – 0.21% 73
2023
Q4 		$556K Hold
2,353
– – 0.13% 75
2023
Q3 		$461K Hold
2,353
– – 0.11% 72
2023
Q2 		$495K Sell
2,353
-465
-17% -$92.5K 0.11% 70
2023
Q1 		$569K Buy
2,818
+463
+20% +$105K 0.13% 68
2022
Q4 		$513K Buy
+2,355
New +$514K 0.11% 77

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return